​

Aura Biosciences (AURA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

AURA Stock Forecast

Aura Biosciences (AURA) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $22.75, with a high of $25.00 and a low of $19.00. This represents a 249.46% increase from the last price of $6.51.

$5 $9 $13 $17 $21 $25 High: $25 Avg: $22.75 Low: $19 Last Closed Price: $6.51

AURA Stock Rating

Aura Biosciences stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 8 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 8 Strong Sell Sell Hold Buy Strong Buy

AURA Price Target Upside V Benchmarks

TypeNameUpside
StockAura Biosciences249.46%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$22.00
Last Closing Price$6.51$6.51$6.51
Upside/Downside--237.94%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 2515---6
Nov, 2514---5
Oct, 2514---5
Sep, 2514---5
Aug, 2534---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 26, 2025Jonathan WollebenJMP Securities$19.00$5.99217.20%191.86%
Mar 25, 2025Edward WhiteH.C. Wainwright$25.00$7.08253.11%284.02%
Oct 18, 2024George FarmerScotiabank$23.00$10.29123.52%253.30%
Oct 18, 2024Ed White IIH.C. Wainwright$22.00$10.29113.80%237.94%
Oct 18, 2024Julian HarrisonBTIG$24.00$10.29133.24%268.66%
Jul 25, 2024Edward WhiteH.C. Wainwright$21.00$9.27126.54%222.58%
Nov 11, 2022JMP Securities$30.00$12.95131.66%360.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 25, 2025Evercore ISIOutperforminitialise
Mar 26, 2025CitigroupOutperformOutperformhold
Mar 25, 2025H.C. WainwrightBuyBuyhold
Oct 18, 2024Cowen & Co.BuyBuyhold
Oct 18, 2024ScotiabankOutperformOutperformhold
Oct 18, 2024ScotiabankSector OutperformSector Outperformhold
Oct 18, 2024H.C. WainwrightBuyBuyhold
Oct 18, 2024BTIGBuyBuyhold
Sep 13, 2024H.C. WainwrightBuyBuyhold
Sep 13, 2024JMP SecuritiesOutperformOutperformhold

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.93$-1.75----
Avg Forecast$-1.84$-1.68$-2.04$-2.13$-2.57$-1.66
High Forecast$-1.84$-1.66$-1.84$-1.90$-2.10$-1.66
Low Forecast$-1.84$-1.70$-2.50$-2.36$-3.04$-1.66
Surprise %4.89%4.17%----

Revenue Forecast

$15M $34M $53M $72M $91M $110M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$18.70M$19.20M$17.50M$109.20M
High Forecast--$18.70M$19.20M$17.50M$109.20M
Low Forecast--$18.70M$19.20M$17.50M$109.20M
Surprise %------

Net Income Forecast

$-125M $-113M $-101M $-89M $-77M $-65M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-76.41M$-86.92M----
Avg Forecast$-72.98M$-66.38M$-85.92M$-84.39M$-101.82M$-65.57M
High Forecast$-72.98M$-65.58M$-72.75M$-75.28M$-83.20M$-65.57M
Low Forecast$-72.98M$-67.17M$-99.10M$-93.50M$-120.44M$-65.57M
Surprise %4.69%30.95%----

AURA Forecast FAQ

Is Aura Biosciences stock a buy?

Aura Biosciences stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 8 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Aura Biosciences is a favorable investment for most analysts.

What is Aura Biosciences's price target?

Aura Biosciences's price target, set by 8 Wall Street analysts, averages $22.75 over the next 12 months. The price target range spans from $19 at the low end to $25 at the high end, suggesting a potential 249.46% change from the previous closing price of $6.51.

How does Aura Biosciences stock forecast compare to its benchmarks?

Aura Biosciences's stock forecast shows a 249.46% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Aura Biosciences over the past three months?

  • December 2025: 16.67% Strong Buy, 83.33% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Aura Biosciences’s EPS forecast?

Aura Biosciences's average annual EPS forecast for its fiscal year ending in December 2025 is $-2.04, marking a 16.57% increase from the reported $-1.75 in 2024. Estimates for the following years are $-2.13 in 2026, $-2.57 in 2027, and $-1.66 in 2028.

What is Aura Biosciences’s revenue forecast?

Aura Biosciences's average annual revenue forecast for its fiscal year ending in December 2025 is $18.7M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $19.2M, followed by $17.5M for 2027, and $109.2M for 2028.

What is Aura Biosciences’s net income forecast?

Aura Biosciences's net income forecast for the fiscal year ending in December 2025 stands at $-85.923M, representing a -1.15% decrease from the reported $-86.919M in 2024. Projections indicate $-84.391M in 2026, $-102M in 2027, and $-65.571M in 2028.